المؤلفون: Elisa Giovannetti, Pier Luigi Zinzani, Romano Danesi, Francesco Crea

المساهمون: Crea F, Giovannetti E, Zinzani PL, Danesi R., Medical oncology laboratory, CCA - Innovative therapy

المصدر: Crea, F, Giovannetti, E, Zinzani, P L & Danesi, R 2009, ' Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization ', Critical Reviews in Oncology / Hematology, vol. 72, no. 1, pp. 21-44 . https://doi.org/10.1016/j.critrevonc.2008.10.014Test
Critical Reviews in Oncology / Hematology, 72(1), 21-44. Elsevier Ireland Ltd

مصطلحات موضوعية: Neutropenia, medicine.medical_treatment, Antineoplastic Agents, Bioinformatics, granulocyte colony stimulating factor, CHEMOTHERAPY-INDUCED NEUTROPENIA, Neoplasms, Granulocyte Colony-Stimulating Factor, medicine, Animals, Humans, Genetic Predisposition to Disease, Chemotherapy, Clinical Trials as Topic, Leukopenia, business.industry, Cancer, Hematology, Omics, medicine.disease, Granulocyte colony-stimulating factor, Oncology, Pharmacogenetics, Immunology, Practice Guidelines as Topic, medicine.symptom, business, Febrile neutropenia

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792cd6f95d4edf26e25853c6f72d69ebTest
https://hdl.handle.net/1871/31310Test

المؤلفون: Enrico Vasile, Carmelo Tibaldi, G. Leticia Leon, Elisa Giovannetti, Armida D'Incecco

المساهمون: Medical oncology laboratory, CCA - Innovative therapy

المصدر: Journal of Cancer Research and Clinical Oncology, 141(7), 1189-1194. Springer Verlag
Vasile, E, Tibaldi, C, Leon, G L, D'Incecco, A & Giovannetti, E 2015, ' Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients ', Journal of Cancer Research and Clinical Oncology, vol. 141, no. 7, pp. 1189-1194 . https://doi.org/10.1007/s00432-014-1880-3Test

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, CYP1B1, medicine.medical_treatment, non-small cell lung cancer (NSCLC), Antineoplastic Agents, Single-nucleotide polymorphism, Docetaxel, Polymorphism, Single Nucleotide, Biomarkers, Pharmacological, Polymorphism (computer science), Carcinoma, Non-Small-Cell Lung, Internal medicine, Tumor Cells, Cultured, medicine, Carcinoma, Humans, neoplasms, Genetic Association Studies, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, Hematology, business.industry, General Medicine, Middle Aged, Prognosis, medicine.disease, body regions, Treatment Outcome, Chemotherapy, Adjuvant, Cytochrome P-450 CYP1B1, Female, Taxoids, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5595da0c67b8409b2e8a1b7b1b23d1Test
https://research.vumc.nl/en/publications/96018efa-575a-443a-b58a-d1486c35ebb8Test

المؤلفون: Sergio Rizzo, Marta Castiglia, Christian Rolfo, Jan P. van Meerbeeck, Giuseppe Cicero, Patrick Pauwels, Francesco Passiglia, Giuseppe Bronte, Francesca Lo Vullo, Antionio Russo, Elisa Giovannetti, Eugenio Fiorentino

المساهمون: Bronte, G, Rolfo, C, Giovannetti, E, Cicero, G, Pauwels, P, Passiglia, F, Castiglia, M, Rizzo, S, Lo Vullo, F, Fiorentino, E, Van Meerbeeck, J, Russo, A, Medical oncology laboratory, CCA - Innovative therapy

المصدر: Bronte, G, Rolfo, C, Giovannetti, E, Cicero, G, Pauwels, P, Passiglia, F, Castiglia, M, Rizzo, S, Lo Vullo, F, Fiorentino, E, van Meerbeeck, J & Russo, A 2014, ' Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects ', Critical Reviews in Oncology / Hematology, vol. 89, no. 2, pp. 300-313 . https://doi.org/10.1016/j.critrevonc.2013.08.003Test
Critical Reviews in Oncology / Hematology, 89(2), 300-313. Elsevier Ireland Ltd
Critical reviews in oncology, hematology

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Lung Neoplasms, EGFR, Erlotinib, Gefitinib, Lung cancer, NSCLC, Tyrosine kinase, Settore MED/06 - Oncologia Medica, Antineoplastic Agents, medicine.disease_cause, Erlotinib Hydrochloride, Growth factor receptor, Pharmacokinetics, Carcinoma, Non-Small-Cell Lung, Internal medicine, Humans, Medicine, Lung, Protein Kinase Inhibitors, neoplasms, business.industry, Hematology, Oncogene Addiction, medicine.disease, respiratory tract diseases, ErbB Receptors, Quinazolines, Human medicine, business, Carcinogenesis, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd84ee94799c56934c065ab33b14bdcTest
https://research.vumc.nl/en/publications/75a54b5d-18f2-46c0-bf46-4c2f125e47dcTest

المؤلفون: Elisa Giovannetti, Godefridus J. Peters, Romano Danesi, Jorn Smit, Ayse Erozenci

المساهمون: Medical oncology laboratory, CCA - Innovative therapy

المصدر: Giovannetti, E, Erozenci, A, Smit, J, Danesi, R & Peters, G J 2012, ' Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice ', Critical Reviews in Oncology / Hematology, vol. 81, no. 2, pp. 103-122 . https://doi.org/10.1016/j.critrevonc.2011.03.010Test
Critical Reviews in Oncology / Hematology, 81(2), 103-122. Elsevier Ireland Ltd

مصطلحات موضوعية: Drug, media_common.quotation_subject, Antineoplastic Agents, Drug resistance, Pharmacology, resistance, microRNA, Cancer stem cell, Neoplasms, Medicine, Animals, Humans, Epigenetics, Precision Medicine, media_common, business.industry, Cancer, Hematology, medicine.disease, MicroRNAs, Oncology, Drug Resistance, Neoplasm, Cancer research, business, Pharmacogenetics, Drug metabolism

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0409c15b0d1b94860841b81f8a3686Test
https://pubmed.ncbi.nlm.nih.gov/21546262Test

المؤلفون: I. Garassino, Jose A. Rodriguez, Giovanni Luca Ceresoli, Giuseppe Giaccone, Armando Santoro, Paolo Andrea Zucali, Paolo M. Comoglio, Elisa Giovannetti, Massimo Roncalli, Karijn Floor, Annarita Destro, Marielle Gallegos Ruiz, Marileila Varella-Garcia

المساهمون: Medical oncology laboratory, Medical oncology, CCA - Innovative therapy

المصدر: Ann Oncol
Annals of Oncology, 19(9), 1605-1612. Oxford University Press
Zucali, P A, Ruiz, M G, Giovannetti, E, Destro, A, Varella-Garcia, M, Floor, K, Ceresoli, G L, Rodriguez, J A, Garassino, I, Comoglio, P, Roncalli, M, Santoro, A & Giaccone, G 2008, ' Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors ', Annals of Oncology, vol. 19, no. 9, pp. 1605-1612 . https://doi.org/10.1093/annonc/mdn240Test

مصطلحات موضوعية: Male, Lung Neoplasms, Kaplan-Meier Estimate, medicine.disease_cause, Tyrosine-kinase inhibitor, Cohort Studies, chemistry.chemical_compound, Carcinoma, Non-Small-Cell Lung, In Situ Hybridization, Fluorescence, Biopsy, Needle, Gefitinib, Hematology, Middle Aged, Protein-Tyrosine Kinases, Immunohistochemistry, ErbB Receptors, Gene Expression Regulation, Neoplastic, Treatment Outcome, Oncology, Female, KRAS, Growth inhibition, medicine.drug, medicine.drug_class, Blotting, Western, medicine, Humans, Lung cancer, neoplasms, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Probability, Proportional Hazards Models, business.industry, Cancer, medicine.disease, Survival Analysis, respiratory tract diseases, lung cancer, chemistry, Drug Resistance, Neoplasm, Multivariate Analysis, Mutation, Cancer research, Quinazolines, Drug Screening Assays, Antitumor, business, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4970f6bb5f4cef2f3972f8facf3929Test
https://europepmc.org/articles/PMC7360138Test/

المؤلفون: Sara Nannizzi, M. Del Tacca, Romano Danesi, Valentina Mey, Elisa Giovannetti, Giuseppe Pasqualetti

المساهمون: Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, AII - Cancer immunology

المصدر: Annals of Oncology, 17(SUPPL. 5). Oxford University Press
Giovannetti, E, Danesi, R, Mey, V, Nannizzi, S, Pasqualetti, G & Del Tacca, M 2006, ' In vitro studies on gemcitabine combinations with other antiblastics ', Annals of Oncology, vol. 17, no. SUPPL. 5 . https://doi.org/10.1093/annonc/mdj943Test

مصطلحات موضوعية: Drug Evaluation, Preclinical, Deoxycytidine, Models, Biological, In vivo, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Tumor Cells, Cultured, medicine, Humans, Drug Interactions, Prodrugs, CYTOTOXICITY, RIBONUCLEOTIDE REDUCTASE, CANCER CELL-LINES, PHARMACOGENETICS, Cisplatin, business.industry, Hematology, Drug interaction, Gemcitabine, In vitro, Pemetrexed, Oncology, Pharmacodynamics, Cancer research, business, Drug metabolism, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bfc1acbf244906cd57d2ad1a6b7745dTest
https://research.vumc.nl/en/publications/6135ccb9-1b99-4846-8a32-ad6f3d4e543eTest